Detail of "20830-75-5"

MSDS Download
CAS Number:
20830-75-5
Name:
Card-20(22)-enolide,3-[(O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3b,5b,12b)-
Superlist Name:
Digoxin
Molecular Structure:
Formula:
C₄₁H₆₄O₁₄
Molecular Weight:
780.94
Deleted CAS:
11000-95-6/36-35-1/39366-41-1/8001-36-3/8001-37-4/8001-52-3/82476-60-6
Synonyms:
Digitoxin,12b-hydroxy- (6Cl);12b-Hydroxydigitoxin;Cardigox;Cardiogoxin;Cardioxin;Cardixin;Cardoxin;Chloroformic digitalin;Coragoxine;Cordioxil;Davoxin;Digacin;Digomal;Digon;Digosin;Digoxin Nativelle;Digoxine;Dilanacin;Dynamos;Eudigox;Grexin;Homolle's digitalin;Lanacordin;Lanocardin;Lanorale;Lanoxicaps;Lanoxin;Lanoxin PG;Lenoxicaps;Lenoxin;Mapluxin;NSC 95100;Natigoxin;NeoDioxanin;Rougoxin;Stillacor;Toloxin;Vanoxin;
EINECS:
244-068-1
Density:
1.36 g/cm³
Melting Point:
248 °C
Boiling Point:
931.6 °C at 760 mmHg
Flash Point:
278.5 °C
Appearance:
White cystalline pwder
Hazard Symbols:
Moderately toxic.T, T+
Risk Codes:
25-26/27/28
Safety:
22-36/37/39-45 Details
Transport Information:
UN 3462 6.1/PG 2

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Level of potassium and calcium in saliva of patients treated with cardiac glycosides: Level of potassium and calcium in saliva of patients treated with cardiac glycosides. Mazurowa, Aleksandra; Drzewoski, Jozef; Szczepanska, Jolanta (Inst. Magn. Werkst., Akad. Med., Lodz, Pol.). Przegl. Lek., 34(3), 349-53 (Polish) 1977. CODEN: PRLKAV. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Levels of K and Ca in the saliva of normal subjects were 17.51 and 3.28 mequiv./L, resp. Patients treated with Lanatoside C [17575-22-3] or digoxin [20830-75-5] and showing no clin. symptoms of overdosage had salivary K and Ca levels of 17.03 and 3.49 mequiv./L, resp., whereas treated patients with symptoms of intoxication showed levels of 27.71 and 4.40 mequiv./L, resp.

The effects of the chronic administration of digoxin on the systolic intervals in a healthy young subject: The effects of the chronic administration of digoxin on the systolic intervals in a healthy young subject. Tomas-Verdera Cosmelli, J.; Garcia del Pozo, J. Maria; Lopez Morales, J.; Palou de Comasema, A.; Morey Molina, A. (Unidad Cardiol., Serv. Med. Interna, Palma de Mallorca, Spain). Rev. Esp. Cardiol., 30(1), 53-7 (Spanish) 1977. CODEN: RCDOAM. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Treatment of normal human subjects with digoxin (I) [20830-75-5] (0.5 mg/day, for 10 days, orally) produced an increase in myocardial contractility, as demonstrated by shortening of systolic intervals, in particular the electromech. systole and the expulsive period. Similar results were obsd. during post-atropine tachycardia.